Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06290902Aexternal-prioritypatent/EP1864668B1/en
Application filed by Novagali Pharma S.A.filedCriticalNovagali Pharma S.A.
Publication of CY1113750T1publicationCriticalpatent/CY1113750T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Steroid Compounds
(AREA)
Abstract
Χρήση μιας σύνθεσης που περιλαμβάνει τουλάχιστον ένα προ-φάρμακο ενός στεροειδούς, κατά προτίμηση ενός κορτικοστεροειδούς, για την παρασκευή μιας οφθαλμικής σύνθεσης που προορίζεται για την θεραπεία μιας οφθαλμικής πάθησης ή ασθένειας ενός ανθρώπου ή ζώου.Use of a composition comprising at least one prodrug of a steroid, preferably a corticosteroid, for the manufacture of an ophthalmic composition intended for the treatment of an eye or disease of a human or animal.
CY20131100153T2006-06-012013-02-20
USE OF PRE-MEDICATIONS FOR EYE INTRODUCTION
CY1113750T1
(en)
THERAPEUTIC AGENT FOR INTESTINAL INFLAMMATORY DISEASE CONTAINING AS AN ACTIVE INGREDIENT A 2-AMINO-1,3-PROPANEDIOL DERIVATIVE OR A METHOD FOR THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASE.